PharmaRoth Labs, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
48/100
80
Valuation
50
Profitability
55
Growth
24
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ROTH research report →
52-Week Range9% of range
Low $0.00
Current $0.00
High $0.00
Companywww.feroindustries.com
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes.
- CEO
- Luis Manuel Ornelas Lopez
- IPO
- 2008
- Employees
- 2
- HQ
- Las Vegas, NV, US
Price Chart
-99.00% · this period
Valuation
- Market Cap
- $3.51K
- P/E
- -0.04
- P/S
- 0.02
- P/B
- -0.01
- EV/EBITDA
- -2.76
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 40.00%
- Op Margin
- -50.44%
- Net Margin
- -50.41%
- ROE
- 17.73%
- ROIC
- 29.61%
Growth & Income
- Revenue
- $181.56K · -31.08%
- Net Income
- $-91,521 · 60.69%
- EPS
- $-0.00 · 66.67%
- Op Income
- $-91,576
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.67
- Avg Volume
- 24
Get TickerSpark's AI analysis on ROTH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ROTH Coverage
We haven't published any research on ROTH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ROTH Report →